Intratympanic Steroids for Sudden Hearing Loss

Not Applicable

• Conditions: Dexamethasone or Methylprednisolone; Sudden Hearing Loss; Intratympanic Steroid
• Interventions: Drug: Dexamethasone or Methylprednisolone

• Registration Number: NCT04129697
• Lead Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Brief Summary

For patients with sudden hearing loss, the initial treatment is not usually effective. We use Dexamethasone or Methylprednisolone to be an Intratympanic steroid administration as a salvage treatment. An randomized, double-blind, multi-center study is designed to find the difference between Dexamethasone or Methylprednisolone.

Detailed Description

Not available

Study Timeline

• Status Verified: 2019-10
• Study First Submitted: 2019-10-15
• Study First Submitted QC: 2019-10-15
• Last Update Submitted: 2019-10-15
• Study First Posted: 2019-10-17
• Last Update Posted: 2019-10-17
• Study Start: 2020-01-01
• Primary Completion: 2021-12-31
• Study Completion: 2022-12-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

sudden hearing loss and initial treatment is not effective

Exclusion Criteria

the patients refused intratympanic steroids treatment.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Dexamethasone	Dexamethasone or Methylprednisolone	-
Methylprednisolone	Dexamethasone or Methylprednisolone	-

Primary Outcome Measures

Name	Time	Method
hearing	six month	the hearing level after treatment